Patients who can benefit the most from targeted treatments are those whose cancers have specific genetic mutations or markers that can be targeted by existing drugs. Diagnostic tests, such as genetic sequencing and biomarker analysis, are often used to identify these mutations. Common cancers that are treated with targeted therapies include certain types of breast cancer, lung cancer, and colorectal cancer.
